Search

Your search keyword '"Abbosh, Christopher"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Abbosh, Christopher" Remove constraint Author: "Abbosh, Christopher"
37 results on '"Abbosh, Christopher"'

Search Results

1. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx

2. The evolution of non-small cell lung cancer metastases in TRACERx

3. The evolution of lung cancer and impact of subclonal selection in TRACERx

4. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

5. Lung adenocarcinoma promotion by air pollutants

6. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

7. Cell-free DNA in early-stage non-small cell lung cancer

8. Tumor-naïve pre-surgical ctDNA detection is prognostic in clinical stage I lung adenocarcinoma

9. Abstract PR011: Comprehensive longitudinal tracking of lung cancer evolutionary clonal dynamics during therapy using circulating tumour DNA

10. ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors

11. Abstract 3384: Evaluation of a tumor informed MRD assay with contrived breast cancer samples

13. Body composition and lung cancer-associated cachexia in TRACERx

14. The evolution of lung cancer and impact of subclonal selection in TRACERx

16. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

17. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

19. Collateral damage: the impact on cancer outcomes of the COVID-19 pandemic

20. Fc effector function contributes to the activity of human anti-CTLA-4 antibodies

21. Abstract 2678: A clonal expression biomarker improves prognostic accuracy: TRACERx lung

22. Artificial intelligence in cancer imaging: Clinical challenges and applications

23. Fc-Optimized Anti-CD25 depletes tumor-infiltrating regulatory T Cells and synergizes with PD-1 Blockade to eradicate established tumors

25. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice

26. Cell-free circulating tumour DNA (ctDNA) in the management of patients (pts) with non-biopsiable (Bx) advanced non-small cell lung cancer (NSCLC).

27. Erratum: Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

28. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

29. The small molecule KHS101 induces bioenergetic dysfunction in glioblastoma cells through inhibition of mitochondrial HSPD1

30. Tracking the Evolution of Non–Small-Cell Lung Cancer

31. A clonal expression biomarker associates with lung cancer mortality

32. CBIO-33INVESTIGATING GLIOMA CELL PHENOTYPES WITH SMALL MOLECULES

34. Publisher Correction: A clonal expression biomarker associates with lung cancer mortality

35. ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors

36. Evolutionary dynamics in pre-invasive neoplasia

37. ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors

Catalog

Books, media, physical & digital resources